Not applicableLooking for participantsNCT04883905What this trial is testingELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)Who this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals 150
Not applicableEnded earlyNCT03547297What this trial is testingINSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHPWho this might be right forAcute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more Alnylam Pharmaceuticals 212
Large-scale testing (Phase 3)Study completedNCT03338816What this trial is testingENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)Who this might be right forAcute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more Alnylam Pharmaceuticals 94
Not applicableApproved For MarketingNCT04056481What this trial is testingExpanded Access Protocol of Givosiran for Patients With Acute Hepatic PorphyriaWho this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals
Not applicableLooking for participantsNCT01561157What this trial is testingLongitudinal Study of the PorphyriasWho this might be right forAcute PorphyriasCutaneous Porphyrias Icahn School of Medicine at Mount Sinai 1,500
Early research (Phase 1)Study completedNCT03505853What this trial is testingInvestigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)Who this might be right forAcute Intermittent Porphyria (AIP)Acute Hepatic Porphyria (AHP)Porphyria, Acute Intermittent+1 more Alnylam Pharmaceuticals 10
Not applicableStudy completedNCT02240784What this trial is testingEXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)Who this might be right forAcute Hepatic Porphyria Alnylam Pharmaceuticals 136